Lithium stocks jumped in premarket trading. Sigma Lithium up 12%; Albemarle, Lithium Americas up over 3%.
Astrazeneca shares rose over 3% in premarket trading as it said Friday that its drug tozorakimab met its primary endpoint in two phase 3 trials in patients with chronic obstructive pulmonary disease.
Optical communications shares jumped in premarket trading. Lumentum, Applied Optoelectronics up around 2%.